Tag: life sciences
-
Precision Cancer Drug Shown Effective in Adults, Children
Results from 3 clinical trials show most cancer patients given an experimental drug that directly addresses a specific genetic mutation respond to the treatments, despite their cancers occurring in a variety of organs.
-
Coalition Standardizes Chronic Kidney Disease Tests
A group of medical lab companies, medical centers, and not-for-profit groups developed standardized testing protocols for chronic kidney disease, which participants expect will help more people diagnose the condition earlier.
-
Trial Shows Treatment Desensitizes Peanut Allergies
A large-scale clinical trial shows a preventive treatment desensitizes peanut allergies in children, with most participants able to tolerate substantial amounts of peanut proteins after 1 year.
-
Pharma, Biotech Partner on Neuro Therapies in $1.1B Deal
Voyager Therapeutics, a developer of gene therapies for neurological disorders, is collaborating with drug maker AbbVie on treatments for diseases resulting from the build-up of damaging proteins in the brain, as in Alzheimer’s disease.
-
RNA Vaccine Shows Promise with Infant Viral Diseases
A vaccine using synthetic RNA, with protein instructions transcribed from one’s genetic code, is shown in tests with lab animals to protect against infections from cytomegalovirus, a virus affecting infants and transplant recipients.
-
Gut Tissue From Stem Cells Simulated on Organ Chips
Researchers created working human gut tissue cells derived from stem cells, grown on plastic chips simulating intestinal diseases, as a tool for testing effectiveness and safety of treatments before given to patients.
-
NIH Exec: Research Offers Opioid Crisis Solutions
The director of the National Institute on Drug Abuse says recent research in neuroscience and pharmacology reveals possible pathways out of the current epidemic of opioid addiction and overdose deaths.
-
Cancer Analytics Company Acquired in $1.9B Deal
The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion.
-
FDA Clears First Blood Test for Concussions
The Food and Drug Administration authorized for marketing in the U.S. a blood test that screens for chemical indicators in the blood for concussions, a form of traumatic brain injury.
-
Patents Awarded for Genetic Editing of CAR T-Cells
U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells.